Rox Medical closes enrollment in a clinical trial of its Rox Coupler, a stent-like device designed to treat hypertension by connecting the femoral vein and the femoral artery.
Rox Medical said it closed enrollment in a 100-patient clinical trial of its Rox Coupler device, designed to treat hypertension by connecting the femoral artery and the femoral vein.
CEO Rodney Brenneman told MassDevice.com that Rox Medical, a Stanford spinout established in 2004 to pursue several indications including chronic obstructive lung disease and heart failure, noticed a dramatic effect on high blood pressure in COPD patients implanted with the device.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1eFZj3Y
Cap comentari:
Publica un comentari a l'entrada